Science News
from research organizations

New mouse model for the study of neurofibromatosis

Date:
April 16, 2015
Source:
IDIBELL-Bellvitge Biomedical Research Institute
Summary:
New mouse models for the study of principal malignant tumor associated with neurofibromatosis type 1 have been developed by researchers. Neurofibromatosis are disorders of the nervous system that primarily affect the development and growth of neural tissue cells.
Share:
FULL STORY

The research group of the neurofibromatosis of the Catalan Institute of Oncology (ICO), the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Institute of Medicicina Predictive and Personalized Cancer (IMPPC) has developed new mouse models for the study of principal malignant tumor associated with neurofibromatosis type 1.

Details of the development and characterization of new animal models have been published in EMBO Molecular Medicine.

Neurofibromatosis, a rare and minority

The neurofibromatosis are disorders of the nervous system that primarily affect the development and growth of neural tissue cells.

Neurofibromatosis type 1 is the most common form, affecting one in 3,500 people, approximately. It is caused by mutations in the NF1 gene, located on chromosome 17. The involvement of this gene can cause a diverse range of health problems, such as tumors on the skin and nervous system.

In this sense, the primary malignant tumor associated with neurofibromatosis type 1 is called malignant tumor of the peripheral nerve sheath. It belongs to the group of soft tissue sarcomas, there is no effective treatment and is associated with poor survival.

New animal models

ICO-IDIBELL-IMPPC team has created what is called orthotopic tumor models, ie have successfully implanted human tumor mouse relevant body and develop as you would in person.

The EMBO Molecular Medicine study shows how the animal model reproduces histological, genetic and epigenetic human tumor characteristics and patterns of spread, which is not achieved with other methods of implementation.

Until now there were no animal models based on direct transplantation of primary tumors originating in these patients. This group has generated five different models using immunosuppressed mice implanted with malignant tumors of peripheral nerve sheath in the same tissue where the tumors originate in humans.

These animal models allow a better study of tumor and promote personalized medicine. If required, you might have a mouse with tumor of each patient so that you can predict how it will develop and decide in each case what the most appropriate treatment for each patient will be.


Story Source:

Materials provided by IDIBELL-Bellvitge Biomedical Research Institute. Note: Content may be edited for style and length.


Journal Reference:

  1. J. Castellsague, B. Gel, J. Fernandez-Rodriguez, R. Llatjos, I. Blanco, Y. Benavente, D. Perez-Sidelnikova, J. Garcia-del Muro, J. M. Vinals, A. Vidal, R. Valdes-Mas, E. Terribas, A. Lopez-Doriga, M. A. Pujana, G. Capella, X. S. Puente, E. Serra, A. Villanueva, C. Lazaro. Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicine. EMBO Molecular Medicine, 2015; DOI: 10.15252/emmm.201404430

Cite This Page:

IDIBELL-Bellvitge Biomedical Research Institute. "New mouse model for the study of neurofibromatosis." ScienceDaily. ScienceDaily, 16 April 2015. <www.sciencedaily.com/releases/2015/04/150416113244.htm>.
IDIBELL-Bellvitge Biomedical Research Institute. (2015, April 16). New mouse model for the study of neurofibromatosis. ScienceDaily. Retrieved May 23, 2017 from www.sciencedaily.com/releases/2015/04/150416113244.htm
IDIBELL-Bellvitge Biomedical Research Institute. "New mouse model for the study of neurofibromatosis." ScienceDaily. www.sciencedaily.com/releases/2015/04/150416113244.htm (accessed May 23, 2017).

RELATED STORIES